keyword
https://read.qxmd.com/read/38669640/a-novel-model-for-xenograft-right-ventricle-to-pulmonary-artery-conduit
#1
JOURNAL ARTICLE
Chace B Mitchell, Luke M Wiggins, Winfield J Wells, David C Cleveland, John D Cleveland
The last 40 years have shown dramatic improvement in outcomes for neonatal cardiac surgery for a spectrum of congenital heart disease diagnoses. With more patients surviving into adulthood, the long-term impact of initial management strategies of these patients has come into focus. This is particularly true for patients with pediatric heart valve disease. Many patients born with right ventricular to pulmonary artery (RVPA) discontinuity require placement of a valved conduit in the neonatal period. Valved conduit options are limited in this patient population due to patient size and inability to respond to somatic growth...
April 18, 2024: ASAIO Journal: a Peer-reviewed Journal of the American Society for Artificial Internal Organs
https://read.qxmd.com/read/38669327/the-role-of-piezo1-mechanotransduction-in-high-grade-serous-ovarian-cancer-insights-from-an-in-vitro-model-of-collective-detachment
#2
JOURNAL ARTICLE
Hannah M Micek, Ning Yang, Mayuri Dutta, Lauren Rosenstock, Yicheng Ma, Caitlin Hielsberg, Molly McCord, Jacob Notbohm, Stephanie McGregor, Pamela K Kreeger
Slowing peritoneal spread in high-grade serous ovarian cancer (HGSOC) would improve patient prognosis and quality of life. HGSOC spreads when single cells and spheroids detach, float through the peritoneal fluid and take over new sites, with spheroids thought to be more aggressive than single cells. Using our in vitro model of spheroid collective detachment, we determine that increased substrate stiffness led to the detachment of more spheroids. We identified a mechanism where Piezo1 activity increased MMP-1/MMP-10, decreased collagen I and fibronectin, and increased spheroid detachment...
April 26, 2024: Science Advances
https://read.qxmd.com/read/38667288/development-and-characterisation-of-a-new-patient-derived-xenograft-model-of-ar-negative-metastatic-castration-resistant-prostate-cancer
#3
JOURNAL ARTICLE
Daniel J Turnham, Manisha S Mullen, Nicholas P Bullock, Kathryn L Gilroy, Anna E Richards, Radhika Patel, Marcos Quintela, Valerie S Meniel, Gillian Seaton, Howard Kynaston, Richard W E Clarkson, Toby J Phesse, Peter S Nelson, Michael C Haffner, John N Staffurth, Helen B Pearson
As the treatment landscape for prostate cancer gradually evolves, the frequency of treatment-induced neuroendocrine prostate cancer (NEPC) and double-negative prostate cancer (DNPC) that is deficient for androgen receptor (AR) and neuroendocrine (NE) markers has increased. These prostate cancer subtypes are typically refractory to AR-directed therapies and exhibit poor clinical outcomes. Only a small range of NEPC/DNPC models exist, limiting our molecular understanding of this disease and hindering our ability to perform preclinical trials exploring novel therapies to treat NEPC/DNPC that are urgently needed in the clinic...
April 12, 2024: Cells
https://read.qxmd.com/read/38666696/macrophage-induced-carboxypeptidase-a4-promotes-the-progression-of-anaplastic-thyroid-cancer
#4
JOURNAL ARTICLE
Yeon-Sook Choi, Min Ji Jeon, Woo Kyung Lee Doolittle, Dong Eun Song, Kyunggon Kim, Won Bae Kim, Won Gu Kim
BACKGROUND: The density of tumor-associated macrophages (TAMs) in the tumor microenvironment of anaplastic thyroid cancer (ATC) is associated with poor prognosis. However, the crosstalk between macrophages and ATC cells is poorly understood. This study aimed to examine the impact of macrophages on cancer cell phenotypes. We found a new mediator between M2 macrophages and ATC cells through proteomics analysis. METHODS: The role of macrophages in proliferation, migration, and invasion of ATC cells was evaluated using co-culture assay and conditioned medium (CM)...
April 26, 2024: Thyroid: Official Journal of the American Thyroid Association
https://read.qxmd.com/read/38664825/sirna-treatment-targeting-integrin-%C3%AE-11-overexpressed-via-ezh2-driven-axis-inhibits-drug-resistant-breast-cancer-progression
#5
JOURNAL ARTICLE
Prakash Chaudhary, Kiran Yadav, Ho Jin Lee, Keon Wook Kang, Jongseo Mo, Jung-Ae Kim
BACKGROUND: Breast cancer, the most prevalent cancer in women worldwide, faces treatment challenges due to drug resistance, posing a serious threat to patient survival. The present study aimed to identify the key molecules that drive drug resistance and aggressiveness in breast cancer cells and validate them as therapeutic targets. METHODS: Transcriptome microarray and analysis using PANTHER pathway and StemChecker were performed to identify the most significantly expressed genes in tamoxifen-resistant and adriamycin-resistant MCF-7 breast cancer cells...
April 25, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38664647/fast-track-adaptation-of-oncolytic-coxsackie-b3-virus-to-resistant-colorectal-cancer-cells-a-method-to-personalize-virotherapy
#6
JOURNAL ARTICLE
Leslie Elsner, Lisanne Heimann, Anja Geisler, Babette Dieringer, Klaus-Peter Knoch, Luisa Hinze, Karin Klingel, Michel Solimena, Jens Kurreck, Henry Fechner
BACKGROUND: The efficacy of oncolytic viruses (OV) in cancer treatment depends on their ability to successfully infect and destroy tumor cells. However, patients' tumors vary, and in the case of individual insensitivity to an OV, therapeutic efficacy is limited. Here, we present a protocol for rapid generation of tumor cell-specific adapted oncolytic coxsackievirus B3 (CVB3) with enhanced oncolytic potential and a satisfactory safety profile. This is achieved by combining directed viral evolution (DVE) with genetic modification of the viral genome and the use of a microRNA-dependent regulatory tool...
April 25, 2024: Biological Procedures Online
https://read.qxmd.com/read/38663220/20-hydroxyecdysone-suppresses-bladder-cancer-progression-via-inhibiting-usp21-a-mechanism-associated-with-deubiquitination-and-degradation-of-p65
#7
JOURNAL ARTICLE
Qiang Ma, Fei Wu, Xiaohui Liu, Cuifang Zhao, Yang Sun, Yuanyuan Li, Wei Zhang, Hongge Ju, Yukun Wang
Bladder cancer is one of the most common malignancies of the urinary tract and a prevalent cancer worldwide, still requiring efficient therapeutic agents and approaches. 20-Hydroxyecdysone (20-HE), a steroid hormone, can be found in insects and few plants and mediate numerous biological events to control the progression of varying diseases; however, its impacts on bladder cancer remain unclear. In the study, we found that 20-HE treatments effectively inhibited the viability and proliferation of bladder cancer cells and induced apoptosis by activating Caspase-3...
April 24, 2024: Translational Oncology
https://read.qxmd.com/read/38663164/circ_0005615-enhances-multiple-myeloma-progression-through-interaction-with-eif4a3-to-regulate-map3k4-m6a-modification-mediated-by-alkbh5
#8
JOURNAL ARTICLE
Kai Zhu, Fengquan Gou, Ziwen Zhao, Ke Xu, Jian Song, Hongyi Jiang, Feng Zhang, Yanli Yang, Jiajia Li
BACKGROUND: Circular RNAs (circRNAs) are associated with development and progression of multiple myeloma (MM). However, the role and mechanism of circ_0005615 in MM have not been elucidated. METHODS: Circ_0005615 was determined by GEO database. quantitative RT-PCR was performed to confirm the expression of circ_0005615 in peripheral blood of MM patients and MM cells. The roles of circ_0005615 in MM were analyzed using CCK8, transwell invasion, cell apoptosis and tumor xenograft experiments...
February 1, 2024: Leukemia Research
https://read.qxmd.com/read/38662438/bridging-the-gap-from-bench-to-bedside-a-call-for-in-vivo-preclinical-models-to-advance-endometrial-cancer-and-cervical-cancer-immuno-oncology-research
#9
JOURNAL ARTICLE
Laura Chambers, Paulina Haight, Julia Chalif, Yogita Mehra, Daniel Spakowicz, Floor J Backes, Casey M Cosgrove, David M O'Malley, Roberto Vargas, Bradley R Corr, Victoria L Bae-Jump, Rebecca C Arend
Advanced-stage endometrial and cervical cancers are associated with poor outcomes despite contemporary advances in surgical techniques and therapeutics. Recent clinical trial results have led to a shift in the treatment paradigm for both malignancies, where immunotherapy is now incorporated in the upfront setting for most patients with advanced endometrial and cervical cancers as the standard of care. Impressive response rates have been observed, but unfortunately, a subset of patients do not benefit from immunotherapy, and survival remains poor...
April 25, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38662247/noni-enhances-the-anticancer-activity-of-cyclophosphamide-and-suppresses-myelotoxicity-and-hepatotoxicity-in-tumor-bearing-mice
#10
JOURNAL ARTICLE
Mohammad Ali, S N Manjula, Ishfaq Mohiuddin, K Mruthunjaya, Faiyaz Shakeel, Suhail Ahmad Mir, Shahid Ud Din Wani
BACKGROUND AND AIM: Morinda citrifolia fruit juice (noni) is an herbal remedy documented to have antioxidant properties. It has been suggested that prevention of carcinogen-DNA adduct formation and the antioxidant activity of NJ may contribute to the cancer preventive effect. In the present study, the antitumor activity of noni was investigated in the presence of cyclophosphamide (CYL) in vitro and in vivo. METHODS: In vitro breast cancer cells (MDA-MB-468) were used to measure the percentage of inhibition and the IC50 ...
April 25, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38662151/pumc-mb1-is-a-novel-group-3-medulloblastoma-preclinical-model-sensitive-to-pi3k-mtor-dual-inhibitor
#11
JOURNAL ARTICLE
Shizun Wang, Dan Zhang, Jialin Wang, Xiaojiao Peng, Hailang Sun, Yuanqi Ji, Zhenli Yang, Xiaocui Bian, Yuhong Hou, Ming Ge, Yuqin Liu
PURPOSE: Medulloblastoma (MB), a common and heterogeneous posterior fossa tumor in pediatric patients, presents diverse prognostic outcomes. To advance our understanding of MB's intricate biology, the development of novel patient tumor-derived culture MB models with necessary data is still an essential requirement. METHODS: We continuously passaged PUMC-MB1 in vitro in order to establish a continuous cell line. We examined the in vitro growth using Cell Counting Kit-8 (CCK-8) and in vivo growth with subcutaneous and intracranial xenograft models...
April 25, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38661516/the-emergence-of-tumor-initiating-cells-in-an-advanced-hypopharyngeal-tumor-model-exhibits-enhanced-angiogenesis-and-nuclear-factor-erythroid-2-related-factor-2-associated-antioxidant-effects
#12
JOURNAL ARTICLE
Min-Ying Lin, Chung-Yih Wang, Yang-Hsiang Chan, Shih-Po Su, Huihua Kenny Chiang, Muh-Hwa Yang, Yi-Jang Lee
Hypopharyngeal cancer (HPC) is associated with the worst prognosis of all head and neck cancers and is typically identified in an advanced stage at the time of diagnosis. While oxidative stress might contribute to the onset of HPC in patients using tobacco or alcohol, the extent of this influence and the characteristics of HPC cells in advanced stage remain to be investigated. In this study, we explored whether HPC cells survived from necrotic xenograft tumors at late stage would display increased tumor resistance along with altered tolerance to oxidative stress...
April 25, 2024: Antioxidants & Redox Signaling
https://read.qxmd.com/read/38660648/upregulated-lncrna-prnt-promotes-progression-and-oxaliplatin-resistance-of-colorectal-cancer-cells-by-regulating-hipk2-transcription
#13
JOURNAL ARTICLE
Sai-Nan Li, Shan Yang, Hao-Qi Wang, Tian-Li Hui, Meng Cheng, Xi Zhang, Bao-Kun Li, Gui-Ying Wang
BACKGROUND: Colorectal cancer (CRC) is the third most common cancer and a significant cause of cancer-related mortality globally. Resistance to chemotherapy, especially during CRC treatment, leads to reduced effectiveness of drugs and poor patient outcomes. Long noncoding RNAs (lncRNAs) have been implicated in various pathophysiological processes of tumor cells, including chemotherapy resistance, yet the roles of many lncRNAs in CRC remain unclear. AIM: To identify and analyze the lncRNAs involved in oxaliplatin resistance in CRC and to understand the underlying molecular mechanisms influencing this resistance...
April 15, 2024: World Journal of Gastrointestinal Oncology
https://read.qxmd.com/read/38660023/egfr-targeting-of-liposomal-doxorubicin-improves-recognition-and-suppression-of-non-small-cell-lung-cancer
#14
JOURNAL ARTICLE
Ernest Moles, David W Chang, Friederike M Mansfeld, Alastair Duly, Kathleen Kimpton, Amy Logan, Christopher B Howard, Kristofer J Thurecht, Maria Kavallaris
INTRODUCTION: Despite improvements in chemotherapy and molecularly targeted therapies, the life expectancy of patients with advanced non-small cell lung cancer (NSCLC) remains less than 1 year. There is thus a major global need to advance new treatment strategies that are more effective for NSCLC. Drug delivery using liposomal particles has shown success at improving the biodistribution and bioavailability of chemotherapy. Nevertheless, liposomal drugs lack selectivity for the cancer cells and have a limited ability to penetrate the tumor site, which severely limits their therapeutic potential...
2024: International Journal of Nanomedicine
https://read.qxmd.com/read/38659807/preclinical-multi-omic-assessment-of-pioglitazone-in-skeletal-muscles-of-mice-implanted-with-human-her2-neu-overexpressing-breast-cancer-xenografts
#15
Stuart A Clayton, Alan D Mizener, Marcella Whetsell, Lauren E Rentz, Ethan Meadows, Werner Geldenhuys, Emidio E Pistilli
UNLABELLED: Breast cancer (BC) is the most prevalent cancer worldwide and is accompanied by fatigue during both active disease and remission in the majority of cases. Our lab has measured fatigue in isolated muscles from treatment-naive BC patient-derived orthotopic xenograft (BC-PDOX) mice. Here, we conducted a preclinical trial of pioglitazone in BC-PDOX mice to determine its efficacy in ameliorating BC-induced muscle fatigue, as well as its effects on transcriptomic, metabolomic, and lipidomic profiles in skeletal muscle...
April 20, 2024: bioRxiv
https://read.qxmd.com/read/38659776/repair-of-leukemia-associated-single-nucleotide-variants-via-interallelic-gene-conversion
#16
Alexander James Silver, Donovan J Brown, Sarah D Olmstead, Jackson M Watke, Agnieszka E Gorska, Londa Tanner, Haley E Ramsey, Michael R Savona
CRISPR-Cas9 is a useful tool for inserting precise genetic alterations through homology-directed repair (HDR), although current methods rely on provision of an exogenous repair template. Here, we tested the possibility of repairing heterozygous single nucleotide variants (SNVs) using the cell's own wild-type allele rather than an exogenous template. Using high-fidelity Cas9 to perform allele-specific CRISPR across multiple human leukemia cell lines as well as in primary hematopoietic cells from patients with leukemia, we find high levels of reversion to wild-type in the absence of exogenous template...
April 20, 2024: bioRxiv
https://read.qxmd.com/read/38659499/horizontal-gbr-with-anorganic-equine-bone-combined-with-a-customized-titanium-mesh
#17
Francesco Orlando, Simone Foiani, Claudia Dellavia, Daniele Graziano, Danilo Alessio Di Stefano
This case report describes the fixed rehabilitation of the lower left arch in a patient following an horizontal GBR procedure by means of a customized titanium mesh and a new slow resorption bone substitute of equine origin.
April 2024: Clinical Case Reports
https://read.qxmd.com/read/38659028/azgp1-deficiency-promotes-angiogenesis-in-prostate-cancer
#18
JOURNAL ARTICLE
Ru M Wen, Zhengyuan Qiu, G Edward W Marti, Eric E Peterson, Fernando Jose Garcia Marques, Abel Bermudez, Yi Wei, Rosalie Nolley, Nathan Lam, Alex LaPat Polasko, Chun-Lung Chiu, Dalin Zhang, Sanghee Cho, Grigorios Marios Karageorgos, Elizabeth McDonough, Chrystal Chadwick, Fiona Ginty, Kyeong Joo Jung, Raghu Machiraju, Parag Mallick, Laura Crowley, Jonathan R Pollack, Hongjuan Zhao, Sharon J Pitteri, James D Brooks
BACKGROUND: Loss of AZGP1 expression is a biomarker associated with progression to castration resistance, development of metastasis, and poor disease-specific survival in prostate cancer. However, high expression of AZGP1 cells in prostate cancer has been reported to increase proliferation and invasion. The exact role of AZGP1 in prostate cancer progression remains elusive. METHOD: AZGP1 knockout and overexpressing prostate cancer cells were generated using a lentiviral system...
April 24, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38658931/cdca5-eef1a1-interaction-promotes-progression-of-clear-cell-renal-cell-carcinoma-by-regulating-mtor-signaling
#19
JOURNAL ARTICLE
Xun Wang, An Shi, Jie Liu, Wen Kong, Yiran Huang, Wei Xue, Fan Yang, Jiwei Huang
BACKGROUND: Cell division cycle associated 5 (CDCA5) plays ontogenetic role in various human cancers. However, its specific function and regulatory mechanism in ccRCC remain uncertain. METHODS: Immunohistochemistry and western blots were performed to investigate the expression of CDCA5 in ccRCC tissues. Genetic knockdown and upregulation of CDCA5 were performed to investigate its functional roles in ccRCC proliferation, migration, apoptosis and sunitinib resistance...
April 24, 2024: Cancer Cell International
https://read.qxmd.com/read/38658865/homoharringtonine-enhances-cytarabine-induced-apoptosis-in-acute-myeloid-leukaemia-by-regulating-the-p38-mapk-h2ax-mcl-1-axis
#20
JOURNAL ARTICLE
Yang Qiu, Lu Bai, Haosen Zhao, Xifan Mei
Acute myeloid leukaemia (AML) is a fatal haematopoietic malignancy and is treated with the conventional combination of cytarabine (Ara-C) and daunorubicin (Dau). The survival rate of AML patients is lower due to the cardiotoxicity of daunorubicin. Clinically, homoharringtonine (HHT) plus Ara-C has been reported to be equally effective as Dau plus Ara-C in some types of AML patients with less toxic effects. We utilized the clinical use of homoharringtonine in combination with Ara-C to test its combination mechanism...
April 24, 2024: BMC Cancer
keyword
keyword
49477
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.